Search Results for: Sienna Biopharmaceuticals Announces First Patient
Articles
March 20, 2018
Sienna Biopharmaceuticals Announces First Patient Dosed in Proof-of-Concept Trial March 20, 2018
Sienna Biopharmaceuticals, Inc. recently announced that the first patient has been dosed in the company’s Phase 1/2 proof-of-concept clinical trial...
October 30, 2017
Sienna Biopharmaceuticals Announces First Patient Dosed in Phase 2b Trial October 30, 2017
Sienna Biopharmaceuticals, Inc. recently announced the first patient has been dosed in the Company’s Phase 2b clinical trial of topical...
December 10, 2018
Sienna Biopharmaceuticals Announces Topical Drug Study Results December 10, 2018
Sienna Biopharmaceuticals, Inc. recently announced top-line results from a Phase 2b study of SNA-120 (pegcantratinib), the company’s lead drug candidate...
